RFK Jr. has been vocal about his desire to reform or “purge” parts of the Food and Drug Administration (FDA), which could introduce uncertainty regarding drug approvals, legal immunity, safety regulations, and market access for new vaccines and pharmaceuticals.
This article Big Pharma’s Big Drop: RFK Jr.’s HHS Nomination Sparks Market Mayhem appeared first on Guerilla Stock Trading.